Status:

UNKNOWN

Confocal Endomicroscopy for Permeability of Esophageal Wall in Refractory Gastroesophageal Reflux Disease (GERD)

Lead Sponsor:

McGuire Research Institute

Collaborating Sponsors:

Hunter Holmes McGuire VA Medical Center

Conditions:

Gastro Esophageal Reflux

Barrett Esophagus

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Confocal Endomicroscopy for Permeability of Esophageal Wall in Refractory Gastroesophageal Reflux Disease (GERD)

Eligibility Criteria

Inclusion

  • Age \> 18 years
  • Ability to give informed consent

Exclusion

  • Pregnancy
  • Esophageal varices
  • Prior esophageal or gastric surgery
  • Active gastrointestinal bleeding
  • Evidence of esophageal malignancy
  • Inability to provide informed consent

Key Trial Info

Start Date :

April 28 2017

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 1 2018

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT03228407

Start Date

April 28 2017

End Date

June 1 2018

Last Update

January 16 2018

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hunter Holmes McGuire VA Medical Center

Richmond, Virginia, United States, 23249

Confocal Endomicroscopy for Permeability of Esophageal Wall in Refractory Gastroesophageal Reflux Disease (GERD) | DecenTrialz